Loading stock data…
SRXH
$0.12+0.01 (+4.74%)
Market ClosedLast close May 1
SRx Health Solutions Inc., through its subsidiaries, engages in the specialty pharmacy and pet health and wellness businesses in the United States, Taiwan, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
SRx Health Solutions Inc. in the Consumer Defensive sector is trading at $0.12. The stock is currently near its 52-week low of $0.08, remaining 54.1% below its 200-day moving average. Technical signals show neutral RSI of 33 and bearish MACD signal, explaining why SRXH maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 33) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$0.12
Potential Upside
5%
Whystock Fair Value$0.13
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
SRx Health Solutions Inc., through its subsidiaries, engages in the specialty pharmacy and pet health and wellness businesses in the United States, Taiwan, and internationally. The company offers pet health and wellness products in multiple forms, in...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$57.72M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-1408.54%
Volume
Today's trading volume
15.78M
Recent News
Why Is Opendoor (OPEN) Stock Rocketing Higher Today
Shares of technology real estate company Opendoor (NASDAQ:OPEN) jumped 7.5% in the afternoon session after SRx Health Solutions, along with its merger partner EMJ Crypto Technologies, announced it increased its investment in the company.
Crypto Currents: Strategy, Galaxy Digital report Q4 earnings results
As bitcoin, ethereum and other cryptocurrencies see major legal, institutional, and technological developments, the financial landscape continues to adapt. Stay up on the crypto news that matters with the “Crypto Currents” weekly from The Fly. Also, join us for your essential daily recap, every day at 2 PM ET on FlyCast radio.Valentine's Day Sale - 70% OffUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and ana
A Look At Opendoor Technologies (OPEN) Valuation As New Stake And Policy Support Refocus Investor Attention
Recent investor interest in Opendoor Technologies (OPEN) has picked up after SRx Health Solutions disclosed a new stake, just as the CEO publicly backed President Trump’s executive order curbing institutional purchases of single-family homes. See our latest analysis for Opendoor Technologies. Those headlines have arrived after a sharp run in Opendoor’s total shareholder return, which is very large over the past year. At the same time, the 90 day share price return of 19.45% and a recent 1 day...
How Investors Are Reacting To Opendoor Technologies (OPEN) After SRx Stake And CEO’s Housing Policy Support
In recent weeks, Opendoor Technologies has drawn attention as SRx Health disclosed a new position in the company and CEO Max Nejatian publicly backed President Trump’s executive order limiting large institutional purchases of single-family homes. This combination of an outside investor signaling confidence and a policy stance aligned with Opendoor’s focus on individual homebuyers adds a fresh angle to how the company is perceived in the housing market. With SRx Health’s investment as a focal...
This Little-Known Penny Stock Is Surging on Digital Asset Treasury News. Should You Buy Shares Here?
SRx Health stock soars as the company announces a major crypto pivot. But investors are cautioned against chasing the momentum in SRXH shares heading into 2026.